porcin
hemagglutin
encephalomyel
viru
phev
caus
porcin
encephalomyel
widespread
among
swine
worldwid
rna
interfer
rnai
pathway
emerg
import
regul
virushost
cell
interact
studi
two
sirna
express
plasmid
gener
target
two
differ
code
region
nucleocapsid
protein
n
phev
shrna
transient
transfect
porcin
kidney
cell
line
determin
whether
construct
inhibit
phev
product
result
reveal
shrna
highli
capabl
inhibit
viral
rna
genom
replic
especi
next
stabl
transfect
use
produc
two
sirna
stabli
express
cell
clone
two
line
infect
phev
analysi
cytopath
effect
cpe
demonstr
capabl
protect
cell
phev
infect
high
specif
effici
furthermor
effect
inhibit
viral
replic
persist
h
tcid
assay
result
indic
rnai
target
n
gene
could
facilit
studi
specif
function
viral
gene
associ
phev
replic
may
potenti
therapeut
applic
consist
nucleotid
nt
jana
et
al
subsequ
rnai
studi
use
synthet
small
interf
rna
sirna
short
hairpin
rna
shrna
extens
studi
interfer
viral
replic
thu
far
replic
variou
virus
includ
mani
coronavirus
effect
inhibit
vitro
vivo
galan
et
al
lambeth
et
al
lan
et
al
wu
et
al
zhao
et
al
zhou
et
al
zhou
et
al
zhuang
et
al
howev
report
shown
replic
phev
cell
cultur
could
disrupt
shrna
target
n
gene
phev
n
extens
phosphoryl
highli
basic
vital
structur
protein
primari
function
form
helic
ribonucleoprotein
complex
viral
rna
vrna
wang
et
al
n
play
import
necessari
role
enhanc
coronaviru
replicon
activ
almazan
et
al
chang
brian
construct
singl
short
hairpin
rna
shrna
plasmid
express
system
target
n
gene
investig
whether
shrnamedi
rna
interfer
could
inhibit
phev
replic
cell
strain
genbank
access
replic
cell
mengel
et
al
prior
infect
phev
cell
maintain
mem
supplement
fetal
bovin
serum
fb
antibiot
gml
streptomycin
uml
penicillin
c
co
incub
overnight
virusinfect
cell
show
cytopath
effect
cpe
cultur
collect
purifi
sucros
densiti
gradient
centrifug
store
c
use
base
recent
research
elbashir
et
al
experi
research
ambion
corpor
jacqu
et
al
use
genbank
sequenc
genbank
access
nc
conserv
area
select
ambion
onlin
sirna
target
design
tool
util
choos
two
best
target
sequenc
target
n
blastn
search
conduct
sequenc
ensur
gene
specif
target
oligonucleotid
insert
plasmid
vector
use
bbsi
bamhi
restrict
site
produc
sequenc
shown
tabl
neg
control
shrna
shnc
target
gttctccgaacgtgtcacgt
sequenc
match
gene
purchas
shanghai
genepharma
co
ltd
shanghai
china
cell
seed
plate
incub
h
c
co
atmospher
cell
confluent
wash
overlaid
transfect
complex
contain
g
g
g
shnc
l
mem
medium
mix
lipofectamin
tm
invitrogen
carlsbad
ca
usa
accord
manufactur
instruct
transfect
complex
complet
remov
incub
h
cell
infect
tcid
phev
nontransfect
cell
use
control
studi
inhibitori
effect
rna
interfer
phev
replic
level
viral
antigen
produc
cell
shrna
transfect
viral
infect
examin
h
postinfect
indirect
immunofluoresc
assay
ifa
use
antiphev
serum
infect
cell
visual
ifa
describ
previous
xu
et
al
posit
antiphev
serum
neg
control
serum
prepar
describ
previous
yu
et
al
cell
wash
three
time
pb
incub
rabbit
antipig
igg
sigma
st
loui
mo
usa
h
wash
cell
photograph
examin
olympu
fv
laser
scan
confoc
microscop
h
postphev
infect
major
nontransfect
cell
cell
transfect
shnc
exhibit
red
fluoresc
cytoplasm
indic
cell
virusproduc
fig
c
contrast
cell
well
treat
transfect
display
red
fluoresc
fig
e
indic
cell
effect
protect
shrna
resist
viral
infect
oligonucleotid
quantit
phev
taqman
realtim
rtpcr
design
use
correspond
genbank
sequenc
genbank
access
nc
conserv
area
select
primer
design
phev
use
primer
express
three
primer
synthes
jikang
shanghai
china
quantif
phev
genom
realtim
pcr
nfp
primer
nrp
primer
taqman
probe
target
region
real
time
rtpcr
span
nucleotid
n
protein
gene
phev
genbank
access
total
rna
ng
extract
purifi
use
trizol
ls
reagent
invitrogen
carlsbad
ca
usa
pcr
use
amplifi
n
gene
nfp
nrp
primer
condit
c
min
follow
cycl
c
c
c
final
extens
c
min
pcr
product
gelpurifi
use
agaros
gel
dna
extract
kit
axygen
union
ca
usa
clone
vector
promega
madison
wi
usa
result
plasmid
ptn
correct
sequenc
confirm
direct
sequenc
select
quantit
standard
determin
viral
rna
copi
number
realtim
pcr
perform
abi
prism
sequenc
detect
system
use
quantitect
tm
probe
pcr
kit
qiagen
hilden
germani
condit
c
min
follow
cycl
denatur
c
anneal
extens
c
quantit
standard
curv
determin
phev
genom
copi
number
creat
realtim
pcr
standard
plasmid
tabl
list
shrna
sequenc
studi
sequenc
shrna
sens
antisens
sens
antisens
underlin
sequenc
target
n
gene
bold
ital
letter
indic
loop
sequenc
near
end
shrna
sens
templat
poli
tract
recogn
termin
signal
rna
pol
iii
termin
shrna
synthesi
end
two
oligonucleotid
noncomplementari
form
bbsi
bamhi
restrict
site
overhang
facilit
effici
direct
clone
plasmid
vector
ptn
prepar
serial
dilut
copiesl
specif
realtim
pcr
confirm
sequenc
product
quantifi
effect
shrna
viral
replic
h
postvir
infect
viral
genom
copi
number
determin
realtim
pcr
use
serial
dilut
plasmid
ptn
standard
r
valu
standard
curv
averag
amplif
effici
e
sequenc
show
amplifi
fragment
contain
expect
portion
phev
genom
therebi
demonstr
specif
reliabl
analysi
shown
fig
copi
number
viral
genom
per
nanogram
total
rna
calcul
standard
curv
copiesng
viral
genom
total
rna
shnctreat
cell
similar
observ
mock
transfect
cell
nontransfect
cell
wherea
copiesng
viral
genom
total
rna
cell
treat
respect
valu
correspond
reduct
respect
substanti
inhibitori
effect
viral
tissu
cultur
infecti
dose
tcid
use
titrat
phev
h
postinfect
briefli
cultur
collect
subject
freezethaw
cycl
serial
dilut
ad
cell
plate
tcid
calcul
use
reed
muench
method
reed
muench
result
fig
show
control
cell
transfect
shnc
phev
tcid
reach
h
postinfect
similar
observ
nontransfect
cell
contrast
titer
h
postinfect
cell
transfect
respect
correspond
reduct
compar
shnctransfect
cell
result
demonstr
especi
block
viral
replic
high
effici
effect
transient
data
shown
conform
effect
use
rna
interfer
rnai
stabli
transfect
line
creat
transfect
cell
per
well
plate
sixwel
plate
transfect
g
shrna
duplex
use
lipofectamin
accord
manufactur
instruct
h
incub
medium
replac
mem
contain
mgml
mainten
week
select
media
resist
cell
clone
name
select
cultur
infect
tcid
phev
per
well
plate
incub
c
variou
time
period
indic
studi
phevinduc
cpe
fig
h
postinfect
cell
examin
phasecontrast
microscopi
everi
h
infect
cell
nontransfect
cell
exhibit
obviou
morpholog
chang
start
brim
well
h
postinfect
loss
monolay
well
round
shrink
cell
analysi
cell
morpholog
indic
neg
control
inhibitori
effect
phevinduc
cpe
compar
mock
control
nontransfect
cell
contrast
trial
group
effect
block
cpe
cell
cultur
h
data
shown
addit
infecti
viru
product
determin
tcid
assay
fig
show
titer
phev
reach
tcid
ml
h
h
h
postinfect
respect
follow
gradual
decreas
titer
h
postinfect
contrast
titer
h
postinfect
tcid
ml
correspond
reduct
respect
titer
h
postinfect
tcid
ml
respect
correspond
reduct
h
postinfect
viral
titer
still
lower
respect
compar
data
indic
shrna
stabli
express
cell
experienc
markedli
inhibit
infecti
viru
product
level
inhibit
decreas
time
progress
confirm
specif
rnai
effect
absenc
interferon
activ
stabli
transfect
line
also
challeng
tcid
pseudorabi
viru
prv
jl
strain
plaqu
count
assay
describ
previous
ferrari
et
al
signific
differ
plaqu
number
plaqu
size
mock
control
nontransfect
cell
stabli
transfect
line
observ
h
prv
infect
shown
fig
phev
known
cov
neurotrop
pig
recent
infect
rate
phev
increas
countri
rho
et
al
thu
pig
without
antibodi
phev
spf
pig
threaten
high
risk
infect
phev
quiroga
et
al
studi
phev
replic
control
inhibit
infect
great
signific
current
effect
prevent
measur
cure
exist
diseas
rnai
provid
effect
antivir
defens
plant
organ
sever
studi
focus
har
rnai
inhibit
viral
infect
leonard
schaffer
howev
effect
sirna
transfect
transient
cell
restrict
low
transfect
effici
shortterm
persist
silenc
effect
recent
fig
viabl
viral
product
two
sirna
stabli
express
cell
clone
mean
three
repeat
titrat
time
point
indic
p
vs
shnc
stabli
express
cell
vectorbas
approach
shrna
interfer
develop
achiev
stabl
longterm
highli
specif
suppress
gene
express
mammalian
cell
siola
et
al
explor
possibl
interrupt
phev
replic
sirna
shrna
sirna
express
plasmid
target
n
gene
phev
synthes
n
play
import
role
viral
packag
process
viral
packag
n
act
bridg
protein
viral
rna
interact
n
mrna
may
affect
viral
rna
transcript
replic
addit
n
highli
conserv
among
coronavirus
express
viral
infect
strong
immunogen
featur
make
n
gene
code
region
good
rnai
target
site
result
shown
fig
stabli
transfect
line
fail
alter
significantli
plaqu
number
size
shown
h
prv
incub
h
viru
infect
respect
medium
remov
cell
fix
stain
number
plaqu
count
data
collect
triplic
well
three
independ
experi
replic
phev
cell
cultur
disrupt
shrna
target
n
gene
phev
clear
studi
dna
vectorbas
shrna
approach
use
rnai
express
plasmid
direct
phev
n
gene
could
effect
block
express
viral
target
gene
inhibit
viral
replic
addit
sirna
therapi
direct
differ
level
viral
function
transcript
translat
base
present
data
advantag
sirna
technolog
believ
sirna
potenti
therapeut
agent
chronic
phev
infect
